Disease Burden and Health-Related Quality of Life (HRQoL) of Chronic Obstructive Pulmonary Disease (COPD) in the US – Evidence from the Medical Expenditure Panel Survey (MEPS) from 2016-2019
DOI: https://doi.org/10.2147/copd.s446696
2024-05-14
International Journal of COPD
Abstract:Melissa H Roberts, 1 David M Mannino, 2, 3 Douglas W Mapel, 4 Orsolya Lunacsek, 5 Shahla Amin, 5 Eileen Farrelly, 5 Norbert Feigler, 6 Michael F Pollack 6 1 College of Pharmacy, University of New Mexico, Albuquerque, NM, USA; 2 College of Medicine, University of Kentucky, Lexington, KY, USA; 3 COPD Foundation, Miami, FL, USA; 4 Northern Arizona Pulmonary Associates, Flagstaff, AZ, USA; 5 Global Consulting, Cencora, Conshohocken, PA, USA; 6 BioPharmaceuticals, US Medical, AstraZeneca, Wilmington, DE, USA Correspondence: Michael F Pollack, BioPharmaceuticals, Global Medical Evidence, AstraZeneca, Wilmington, DE, USA, Email Purpose: Chronic obstructive pulmonary disease (COPD) is a progressive disease associated with reduced life expectancy, increased morbidity, mortality, and cost. This study characterized the US COPD burden, including socioeconomic and health-related quality of life (HRQoL) outcomes. Study Design and Methods: In this retrospective, cross-sectional study using nationally representative estimates from Medical Expenditures Survey (MEPS) data (2016– 2019), adults (≥ 18 years) living with and without COPD were identified. Adults living without COPD (control cohort) and with COPD were matched 5:1 on age, sex, geographic region, and entry year. Demographics, clinical characteristics, socioeconomic, and generic HRQoL measures were examined to include a race-stratified analysis of people living with COPD. Results: A total of 4,135 people living with COPD were identified; the matched dataset represented a weighted non-institutionalized population of 11.3 million with and 54.2 million people without COPD. Among people living with COPD, 66.3% had ≥ 1 COPD-related condition; 62.7% had ≥ 1 cardiovascular condition, compared to 33.5% and 50.5% without COPD. More people living with COPD were unemployed (56.2% vs 45.3%), unable to work due to illness/disability (30.1% vs 12.1%), had problems paying bills (16.1% vs 8.8%), reported poorer perceived health (fair/poor: 36.2% vs 14.4%), missed more working days due to illness/injury per year (median, 2.5 days vs 0.0 days), and had limitations in physical functioning (40.1% vs 19.4%) (all P < 0.0001). In race-stratified analyses for people living with COPD, people self-reporting as Black had higher prevalence of cardiovascular-risk conditions, poorer socioeconomic and HRQoL outcomes, and higher healthcare expenses than White or Other races. Conclusion: Adults living with COPD had higher clinical disease burden, lower socioeconomic status, and reduced HRQoL than those without, with greater disparities among Black people living with COPD compared to White and other races. Understanding the characteristics of patients helps address care disparities and access challenges. Keywords: COPD, burden of illness, healthcare cost, race/ethnicity Chronic obstructive pulmonary disease (COPD) is a progressive disease characterized by persistent respiratory symptoms 1 and occasional exacerbations leading to significant disease and economic burden on the US healthcare system. 2,3 In 2019, direct medical expenditures attributable to COPD generated using Medical Expenditure Panel Survey (MEPS) data were estimated at 60.5 billion in 2029. 4 Direct cost estimates do not present a complete picture of the disease burden, as COPD has been shown to negatively impact socioeconomic outcomes, healthcare resource utilization (HCRU), and health-related quality of life (HRQoL). 2,5 Among adults reporting a diagnosis of COPD, in a 2011 Behavioral Risk Factor Surveillance System (BRFSS) survey assessing the impact of COPD and reduced lung function, 64.2% of respondents reported that shortness of breath negatively impacted their HRQoL. 6 Based on the 2008 to 2012 MEPS data of people aged ≥40 years living with COPD, asthma, or both, compared to other concurrent medical conditions, COPD contributed the most to all-cause and respiratory hospitalizations and emergency department (ED) visits. 7 Additionally, there is some evidence that the experiences individuals have living with COPD may differ across racial and socioeconomic groups. Data from 1980 to 2000 showed that Black people living with COPD experienced higher hospitalization rates and ED visits and reported fewer scheduled physician office visits than non-Hispanic White people. 8 A study by Sarrazin et al 9 reported that Black individuals are at a higher risk of severe COPD exacerbations and suggested that racial disparities in disease management services such as vaccination pro -Abstract Truncated-
respiratory system